维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="Badro"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk显示文摘	Michella Ghassibe-Sabbagh Daniel E. Platt Sonia Youhanna Antoine B. Abchee Krista Stewart Danielle A. Badro Marc Haber Angelique K. Salloum Bouchra Douaihy Hamid el Bayeh Raed Othman Nabil Shasha Samer Kibbani Elie Chammas Aline Milane Rita Nemr Yoichiro	2012	Atherosclerosis2012，，1：	1
2	Oxygen as a light element: A solution to single-stage core formation 显示文摘	Corgne A Siebert J Badro J	2009	Earth and Planetary Science Letter2009，288，：	1
3	Prevalence and significance of vitamin D deficiency in multiple myeloma patients显示文摘	Badros A Goloubeva O Terpos E	2008	Br J Haematol2008，142，3：	1
4	Improved outcome of non-myeloablative allogeneic transplantation in multiple myeloma显示文摘	Barlogle B Siegel E	2002	J Clin Oncol2002，20，：	1
5	Carfilzomib in multiple myeloma patients with renal impairment:pharmacokinetics and safety显示文摘	Badros AZ Vij R Martin T	2013	Leukemia2013，27，8：	1
6	Effect of zoledronie acidon oral broblasts and epithelial cells phonate-associated osteonecrosis显示文摘	Scheper MA Badros A Chaisuparat R	2009	a potential mechanism of bisphos- Br J Haematol2009，144，5：	1
7	Bevacizumab therapy for PO EMS syndrome显示文摘	Badros A Porter N Zimrin A	2005	Blood2005，105，3：	1
8	Phase Ⅰ study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma显示文摘	Badros A Burger AM Philip S		0，，：	1
9	Bevacizumab therapy for POEMS syndrome显示文摘	Badros A Porter N Zimrin A	2005	Blood2005，106，3：	1
10	Magnetism in FeO at Megabar Pressures from X-Ray Emission Spectroscopy显示文摘	Badro J Struzhkin V V Shu J F	1999	Phys Rev Lett1999，83，：	1
11	Bevacizumab therapy for POEMS syndrome显示文摘	Badros A Porter N Zimrin A	2005	Blood2005，106，3：	1
12	Neurotoxicity of bortezomib therapy in multiple myeloma:a single-center experience and review of the literature显示文摘	Badros A goloubeva O Dalal JS	2007	Cancer2007，110，5：	1
13	Bevacizumab theraphy for POEMS syndrome显示文摘	Badros A Porter N Zimrin A	2005	Blood2005，106，3：	1
14	Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma 显示文摘	BADROS A BURGER A M PHILIP S	2009	Clin Cancer Res2009，15，16：	1
15	Phase II study of G3139, a Bcl-2 antisense oligonucleotide , in combination with dexamethason and thalidomide in relapsed multiple myeloma patients 显示文摘	Badros AZ Goloubeva O Rapoport AP etal	2005	J Clin Oncol2005，23，18：	1
16	Pressure-induced electronic spin transition of iron in magnesiowustite-(Mg,Fe)O显示文摘	BADRO J STRUZHKIN V V SHU J	1999	Phys Rev Lett1999，83，：	1
17	A novel bioassay model to determine clinically significant bisphosphonate levels显示文摘	Mark A. Scheper Ashraf Badros Andrew R. Salama Gary Warburton Kevin J. Cullen Dianna S. Weikel Timothy F. Meiller	2009	Supportive Care in Cancer2009，，12：	1
18	Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma显示文摘	Badros A Burger AM Philip S		0，，16：	1
19	Neurotoxicity of borte- zomib therapy in multiple myeloma: a single- center experi- ence and review of the literature 显示文摘	Badros A Goloubeva O Dalal JS	2007	Cancer2007，110，5：	1
20	Phase Ⅱ study of G3139, a Bcl-2 antisense oligonueleotide, in combination with dexamethason and thalidomide in relapsed multiple myeloma patients显示文摘	Badros AZ Goloubeva Q Rapoport AP	2005	J Clin Oncol2005，23，18：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示